Dyno Therapeutics develops technologies for safe, efficient and targeted in vivo delivery of new gene therapies and genome editing therapies. Our data-driven approach combines next-generation DNA synthesis of millions of AAV capsids with high-throughput sequencing and machine learning.
- Eric Kelsic, PhD Founder & CEO
- Alan Crane, MBA Founder & Executive Chair
- Shimyn Slomovic, PhD Founder & Head of Molecular & Synthetic Biology
- Adrian Veres Scientific Founder
- Sam Sinai Scientific Founder
- George Church, PhD Scientific Founder